Age and sex for each experimental group
| Diagnosis | Overall | Set 1 | Set 2 | ||||||
| N | Mean age | Female | N | Mean age | Female | N | Mean age | Female | |
| AT biopsy (SD) | % | AT biopsy (SD) | % | AT biopsy (SD) | % | ||||
| TAO | 25 | 51.6±14.0 | 76 | 14 | 54.0±14.7 | 79 | 11 | 48.6±13.0 | 73 |
| GPA | 6 | 40.2±12.2 | 67 | 4 | 43.4±14.3 | 75 | 4* | 40.0±13.9 | 50 |
| Sarcoidosis | 7 | 45.8±12.0 | 71 | 1 | 60.6‡ | 100 | 7† | 48.8±14.7 | 71 |
| NSOI | 25 | 50.4±23.5 | 64 | 14 | 44.0±21.8 | 64 | 11 | 58.5±24.1 | 64 |
| Normal | 20 | 63.6±14.5 | 70 | 14 | 61.0±15.6 | 64 | 6 | 69.7±9.8 | 83 |
*Two repeated from set 1.
†One repeated from set 1
‡Excluded from reliability analysis
GPA, granulomatosis with polyangiitis; NSOI, non-specific orbital inflammation; TAO, thyroid-associated orbitopathy.